The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related ...

Discover the history, evolution, and importance of clinical trials, from James Lind's scurvy study to modern registry ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect ...

Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial:Tel Aviv University (TAU)’s Institute for Psychedelic Research locate ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

SNIPR Biome ApS ("SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, today announced that the first patient has been dosed in ...

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...

Diversity in clinical trials can positively impact patient care and outcomes, particularly among minority populations, Anita ...